InvestorsHub Logo
Post# of 252730
Next 10
Followers 122
Posts 8884
Boards Moderated 0
Alias Born 10/05/2004

Re: mcbio post# 114743

Monday, 02/14/2011 7:45:02 PM

Monday, February 14, 2011 7:45:02 PM

Post# of 252730
Glad to be in the same stock with you. Just a reminder of the deal they have with SLXP which is a very impressive company:

"Salix Pharmaceuticals Ltd. said Monday that it will pay $60 million up front – and possibly hundreds of millions of dollars long term ­– to license a constipation drug named Relistor from Progenics Pharmaceuticals Inc.

In addition to the upfront payment, Morrisville-based Salix also could pay up to $90 million in U.S. development milestones, according to a written statement issued by the companies. In addition, Salix may pay sales-based milestones of as much as $200 million plus royalties from U.S. sales, as well as 60 percent of all revenue received from non-U.S. sublicensees.

Read more: Salix pays $60M to license Relistor from Progenics | Triangle Business Journal"




It's very impressive that SLXP would give so much to PGNX under this deal. PGNX has a market cap of around $150 million which is ridiculously low given this deal.

Btw, if you are looking for another bio play, i suggest AMRN. i like that one a lot too. Bought in around $5 and still holding

"Don't worry about the world coming to an end today. It's already tomorrow in Australia"

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.